Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) and Trianni, Inc. (“TRIANNI”) today announced that the companies have entered...